94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Adrián Mosquera Orgueira1*†Andrés Peleteiro Raíndo1†
José Ángel Díaz Arias1
Beatriz Antelo Rodríguez1Mónica López Riñón2
Claudio Cerchione3
Adolfo de la Fuente Burguera4
Marta Sonia González Pérez1
Giovanni Martinelli3Pau Montesinos Fernández5Manuel Mateo Pérez Encinas1- 1Department of Hematology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
- 2Department of Hematology, Tomelloso Hospital, Ciudad Real, Spain
- 3Unit of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
- 4Department of Hematology, MD Anderson Cancer Center, Madrid, Spain
- 5Department of Hematology, Hospital La Fe, Valencia, Spain
A corrigendum on
Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
by Mosquera Orgueira A, Peleteiro Raíndo A, Díaz Arias JÁ, Antelo Rodríguez B, López Riñón M, Cerchione C, de la Fuente Burguera A, González Pérez MS, Martinelli G, Montesinos Fernández P and Pérez Encinas MM (2022) Front. Oncol. 12:968340. doi: 10.3389/fonc.2022.968340
In the published article, there was an error in affiliations 3 and 4. Instead of “3Department of Hematology, MD Anderson Cancer Center, Madrid, Spain, 4Unit of Hematology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Istituto Tumori della Romagna IRST IRCCS, Meldola, Italy”, it should be “3Unit of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, 4Department of Hematology, MD Anderson Cancer Center, Madrid, Spain”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: leukemia, transcriptome, machine learning, survival, risk, prediction
Citation: Mosquera Orgueira A, Peleteiro Raíndo A, Díaz Arias JÁ, Antelo Rodríguez B, López Riñón M, Cerchione C, de la Fuente Burguera A, González Pérez MS, Martinelli G, Montesinos Fernández P and Pérez Encinas MM (2023) Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia. Front. Oncol. 13:1302993. doi: 10.3389/fonc.2023.1302993
Received: 27 September 2023; Accepted: 28 September 2023;
Published: 04 October 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Mosquera Orgueira, Peleteiro Raíndo, Díaz Arias, Antelo Rodríguez, López Riñón, Cerchione, de la Fuente Burguera, González Pérez, Martinelli, Montesinos Fernández and Pérez Encinas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Adrián Mosquera Orgueira, YWRyaWFuLm1vc3F1ZXJhLm9yZ2VpcmFAc2VyZ2FzLmVz
†These authors have contributed equally to this work and share first authorship